(Q33684288)

28 July 2017

title

Protection of non-human primates against rabies with an adenovirus recombinant vaccine (English)

1 reference

28 July 2017

0 references

1 reference

Z Q Xiang

1

1 reference

28 July 2017

L Greenberg

series ordinal

2

1 reference

28 July 2017

H C Ertl

series ordinal

3

1 reference

28 July 2017

C E Rupprecht

series ordinal

4

1 reference

28 July 2017

language of work or name

English

0 references

publication date

9 January 2014

1 reference

28 July 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Virology

1 reference

28 July 2017

volume

450-451

1 reference

28 July 2017

page(s)

243-249

1 reference

First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

ChAd63-MVA-vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

From brain passage to cell adaptation: the road of human rabies vaccine development

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

An efficient method of directly cloning chimpanzee adenovirus as a vaccine vector

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

The immune response to rabies virus infection and vaccination

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

Adenovirus-specific human T cells are pervasive, polyfunctional, and cross-reactive

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

Increased immunofluorescent staining of rabies-infected, formalin-fixed brain tissue after pepsin and trypsin digestion

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

Therapy of rabies encephalitis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

Survival of neutralizing antibody in previously rabies vaccinated subjects: a prospective study showing long lasting immunity

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4038128

Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America.

30 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.12.029

Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.12.029

The global availability of rabies immune globulin and rabies vaccine in clinics providing direct care to travelers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.12.029

The blueprint for rabies prevention and control: a novel operational toolkit for rabies elimination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.12.029

Measurement of rabies antibody: comparison of the mouse neutralization test (MNT) with the rapid fluorescent focus inhibition test (RFFIT)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.12.029

Oral immunization of rhesus macaques with adenoviral HIV vaccines using enteric-coated capsules.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.12.029

Eliminating canine rabies, the principal source of human infection: what will it take?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.12.029

Correlates of protection induced by vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.12.029

Pre-exposure prophylaxis against rabies in children: safety of purified chick embryo cell rabies vaccine (Vaxirab N) when administered by intradermal route

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.12.029

Evidence for a 4-dose vaccine schedule for human rabies post-exposure prophylaxis in previously non-vaccinated individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.12.029

Oral vaccination of dogs with recombinant rabies virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.12.029

Poxvirus-vectored vaccines for rabies--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.12.029

Therapeutic potential of adenovirus as a vaccine vector for chronic virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2013.12.029

Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24503087

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Induction of genital immunity by DNA priming and intranasal booster immunization with a replication-defective adenoviral recombinant

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24503087

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2013.12.029

1 reference

28 July 2017

1 reference

28 July 2017

1 reference